Investment Rating - The report maintains an "Outperform" rating for China Feihe [2][15]. Core Insights - The company reported total revenue of RMB 18.11 billion for 2025, a decrease of 12.7% year-over-year, and a net profit attributable to shareholders of RMB 1.94 billion, down 45.7% year-over-year, which fell short of market expectations [3][11]. - In the second half of 2025, revenue was RMB 8.96 billion, down 15.9% year-over-year, while net profit attributable to shareholders was RMB 940 million, down 44.6% year-over-year, although the decline in profits narrowed and operating margins improved [3][11]. - The company has proactively optimized channel inventory and controlled shipment schedules since May 2025, which, along with reduced government subsidies and impairment of biological assets, has placed short-term pressure on performance. However, following inventory destocking, fundamentals have strengthened, laying the foundation for profit recovery [3][11]. Revenue and Profit Forecast - Revenue is projected to be RMB 18.73 billion, RMB 19.47 billion, and RMB 20.36 billion for 2026, 2027, and 2028, respectively, with net profit attributable to shareholders expected to be RMB 2.41 billion, RMB 2.57 billion, and RMB 2.76 billion for the same years [5][15]. - The estimated diluted EPS for 2026, 2027, and 2028 is RMB 0.27, RMB 0.28, and RMB 0.30, respectively [5][15]. Business Structure and Growth - The business structure continues to optimize, with the core infant formula business generating RMB 15.87 billion, accounting for 87.6% of total revenue, and maintaining a market share of 19% [4][12]. - New product launches have shown promising results, with the newly launched products Jiecu and Qicu generating over RMB 69 million in revenue within a month of their release [4][12]. - The company is expanding its overseas business, with revenue from the U.S. and Canada reaching RMB 180 million and RMB 50 million, respectively, showing year-over-year growth of 11.7% and 23.3% [4][12]. Cost Management and Financial Health - The consolidated gross margin for the year was 65.0%, down 1.3 percentage points year-over-year, primarily due to an increased proportion of low-margin raw material powder revenue. However, the gross margin for infant formula powder improved to 73.5%, up 2.2 percentage points year-over-year [13]. - The company holds net cash of RMB 16.2 billion, indicating robust operating cash flow [13][14].

Core Viewpoint - The company reported a decline in revenue and net profit for 2025, with a focus on adjusting its infant formula business and expanding its lifecycle nutrition system in response to increased competition and weak demand [1][2]. Financial Performance - In 2025, the company achieved a main revenue of 18.113 billion yuan, down 12.7% year-on-year, and a net profit of 1.939 billion yuan, down 45.7% year-on-year [1]. - For the second half of 2025, the main revenue was 8.962 billion yuan, a decrease of 15.9% year-on-year, and net profit was 939 million yuan, down 44.6% year-on-year [1]. - The company proposed a final dividend of 0.129 HKD per share, along with a mid-term dividend of 0.1209 HKD, totaling a dividend payout of 2.03 billion yuan for 2025, with a dividend rate of 104.85% [1]. Market Dynamics - The infant formula sector faced weak demand and intensified competition, with newborn numbers declining to 7.92 million after a brief recovery in 2024 [1]. - The company's market share in the infant formula industry decreased to 19% in 2025 from 20.5% in 2024 [2]. Product Performance - Key products such as Xingfeifan, Zhuorui, and Zhuoyao generated revenues of 4.3 billion, 6.5 billion, and 710 million yuan respectively, with Zhuorui showing a relatively stable performance with a 3% decline [1]. - The company’s gross margin improved significantly to 68.52% in the second half of 2025, up 3.63 percentage points year-on-year, attributed to cost savings from in-house production of core raw materials [1]. Strategic Initiatives - The company is actively adjusting its infant formula offerings by launching new products and enhancing operational strategies, including a focus on international markets [2]. - Plans for 2026 include launching high-end goat milk powder and customized products, as well as expanding into North America, Mexico, and Indonesia [2]. - The company aims to develop a lifecycle nutrition system, targeting revenue of 300 million yuan from children's nutrition products and 400 million yuan from adult functional nutrition by 2026 [3]. Investment Outlook - The company is expected to see some recovery in operations in 2026, with projected revenues of 2.46 billion, 2.56 billion, and 2.65 billion yuan for 2026-2028 [3]. - The current dividend yield is 6.8%, providing a degree of certainty in returns, with a target valuation of 14 times earnings, corresponding to a target price of 4.3 HKD [3].

Investment Rating - The report maintains an "Accumulate" rating for China Feihe (6186.HK) with a current price of HKD 3.68 [1] Core Insights - In 2025, China Feihe achieved revenue of CNY 18.11 billion, a year-on-year decrease of 12.7%, and a net profit attributable to shareholders of CNY 1.94 billion, down 45.7% [4][5] - The infant formula business, which accounts for 88% of total revenue, faced pressure due to declining birth rates and increased competition, resulting in a revenue decline of 16.8% [5] - Despite challenges, the company remains a market leader with a 19% market share and high brand recognition [5] - New high-end products launched in 2025 have shown promising performance and are expected to contribute to revenue growth [5][8] - The company plans to maintain a high dividend policy, distributing no less than CNY 2 billion in dividends for 2025 [7] Financial Performance Summary - Revenue and profit forecasts for 2026-2028 have been adjusted downwards due to weak demand for infant formula, with projected net profits of CNY 2.29 billion in 2026 and CNY 2.45 billion in 2027 [8][11] - The overall gross margin for 2025 was 65.0%, a decrease of 1.3 percentage points, primarily due to an increase in low-margin raw material sales [7] - The company has a strong cash flow position, with operating cash flow projected to improve in the coming years [13] Market Expansion - In 2025, overseas revenue reached CNY 230 million, with significant growth in the Canadian market, where the company received its first foreign infant formula production license [8] - Plans for 2026 include entering the U.S. and Mexican markets, further expanding North American operations [8] Valuation and Earnings Forecast - The current stock price corresponds to a price-to-earnings ratio of 13x for 2026, 12x for 2027, and 11x for 2028, indicating a favorable valuation for a leading player in the domestic milk powder industry [8][11]

Core Viewpoint - The article emphasizes the need for improving the quality and quantity of protein intake among the Chinese population, highlighting the structural issues in the dairy industry, including insufficient deep processing capabilities and reliance on imported raw materials [2][3]. Group 1: Protein Intake Issues - The current protein intake level in China is inadequate, particularly in terms of high-quality protein, with an average daily intake of 60.4g compared to 93.9g in the U.S. and 71.4g in Japan [4][6]. - Over 55% of parents report that their children consume a limited variety of protein sources, and nearly 90% of elderly individuals reduce their protein intake due to health misconceptions, leading to serious health issues like sarcopenia [6][8]. - There is a significant gap in consumer awareness regarding protein nutrition, with 70% of respondents unaware of how to scientifically supplement protein [8]. Group 2: Supply-Side Challenges - The domestic supply of quality protein has not kept pace with demand, with a protein self-sufficiency rate dropping from 96% to 69% between 2000 and 2021 [8]. - The dairy industry faces structural imbalances, with liquid milk accounting for 92.7% of production, while high-value products like cheese and butter make up less than 7.3% [9][10]. - The reliance on imports for key dairy ingredients, such as whey protein, poses a risk to supply stability, especially given the geopolitical uncertainties [9][10]. Group 3: Recommendations for Improvement - The article suggests that the government should create a differentiated protein intake guideline for various demographics, including infants, adults, and the elderly, to enhance consumer education [8]. - It advocates for policies that support domestic innovation in the protein industry, including tax incentives and funding for research and development [10]. - The focus should be on technological breakthroughs in dairy processing to enhance the supply chain's resilience and ensure food security [10][11]. Group 4: Technological Advancements - The company has made significant strides in dairy protein deep processing, establishing China's first automated production line for lactoferrin and developing innovative extraction technologies [11][12]. - The company has achieved 100% self-research and production capability for key dairy ingredients, creating a comprehensive technical system from research to commercialization [13]. - The advancements in technology not only improve product quality but also address the industry's long-standing issues of dependency on imports and structural imbalances [15][21]. Group 5: Holistic Approach to Nutrition and Industry - The company's strategy aims to create a closed-loop system that integrates nutrition education, industry upgrades, and self-sufficiency, ultimately benefiting both public health and the dairy sector [16][21]. - By focusing on technical innovation, the company seeks to extend its nutritional solutions beyond infant formula to cater to all age groups, addressing the broader issue of protein intake across the population [17][20].

Core Viewpoint - The article highlights the launch of Feihe's new fresh ingredient traceability system, marking a significant advancement in the infant formula industry and redefining the standards of "freshness" in baby formula products [3][10][22]. Group 1: Event Overview - The "Seeking Traces · Fresh Vitality Ceremony" was held in Beijing, featuring brand ambassadors and industry experts discussing Feihe's new products and their commitment to "fresh nutrition" [1][12]. - The event showcased Feihe's new products, "Jilu" and "Qicui," which utilize the fresh ingredient traceability system, emphasizing their superior quality and nutritional benefits [12][22]. Group 2: Fresh Ingredient Traceability System - Feihe introduced the world's first traceability system for fresh ingredients in infant formula, allowing consumers to track the production information of key ingredients like whey protein and lactoferrin through a simple QR code [6][7]. - This system transforms product quality into transparent, perceivable data, enhancing consumer trust and safety in product selection [7][10]. Group 3: Industry Impact - The introduction of the traceability system signifies the beginning of the third "freshness revolution" in the infant formula industry, pushing for higher standards and transparency in the supply chain [3][10][22]. - Feihe's commitment to self-sourcing fresh ingredients aims to mitigate risks associated with imported raw materials, such as contamination and nutrient loss [7][10]. Group 4: Product Innovations - The new products "Jilu" and "Qicui" are designed to be more suitable for Chinese babies, featuring advanced formulations that enhance freshness and nutritional value, achieving a freshness level 23 times higher than traditional imported ingredients [12][21]. - These products are backed by rigorous clinical trials, ensuring their effectiveness in promoting growth and development in infants [21][22]. Group 5: Research and Development - Feihe has invested over 64 years in maternal milk research, collaborating with top research institutions globally to build the largest maternal milk database in China, which supports their innovative product development [19][22]. - The company has achieved significant recognition in the field, holding the top position in maternal milk research outcomes and patents in infant formula [19].

Core Viewpoint - The event "Seeking Traces · Fresh Vitality Ceremony" held by Feihe in collaboration with Harper's Bazaar marks the launch of two new products, "Jilu" and "Qicui," which embody the concept of "fresh nutrition" and emphasize the importance of fresh raw materials in infant formula [1][10]. Group 1: New Product Launch and Innovations - Feihe has introduced a fresh raw material traceability system, allowing consumers to trace the production information of key ingredients like whey protein and lactoferrin through a simple QR code scan [3][4]. - The new products "Jilu" and "Qicui" utilize Feihe's self-produced fresh raw materials, achieving a freshness level at least 23 times higher than traditional imported ingredients [10][19]. - The traceability system signifies an upgrade in the freshness standards of the infant formula industry, marking the beginning of the third "fresh revolution" in the sector [6][8]. Group 2: Industry Leadership and Research - Feihe has established a self-controlled model by building its own farms since 2006, addressing the freshness issue at the source and setting a precedent for domestic infant formula companies [8]. - The company has been deeply involved in breast milk research for 64 years, collaborating with over 20 top research institutions globally, and has built a comprehensive breast milk database [15]. - Feihe has achieved significant recognition, holding the top position in breast milk research results, infant formula patents, and maternal source formula nutrition in China [15]. Group 3: Consumer Engagement and Brand Ambassadors - The event featured brand ambassadors Zhu Zhu and Xi Mengyao, who shared their personal experiences and emphasized the importance of transparency and safety in choosing infant formula [12][14]. - The "Star Mom Talk" segment allowed mothers to discuss the "fresh vitality" concept, reinforcing the effectiveness of Feihe's products through real user experiences [14]. Group 4: Future Directions and Industry Impact - The introduction of "Jilu" and "Qicui" represents a shift in the industry from superficial competition to a deeper focus on fresh raw material systems and product efficacy verification [19][20]. - Feihe aims to lead the infant formula industry into a new era centered on "fresh nutrition" as a core competitive advantage, influencing future purchasing standards for parents [20].

Core Viewpoint - The launch of the world's first fresh raw material traceability system for infant formula by Feihe marks a significant advancement in the industry, establishing "raw material freshness" as a core evaluation dimension for formula quality [1][2]. Group 1: Fresh Raw Material Traceability System - Feihe's new traceability system allows consumers to scan a QR code to access production dates and trace the origins of key ingredients like whey protein and lactoferrin, enhancing transparency and consumer trust [1][2]. - This system represents an upgrade in the freshness standards of the Chinese infant formula industry, making safety and freshness more visible to consumers [1]. Group 2: Industry Innovations and Standards - Feihe has pioneered a self-controlled model by establishing its own farms since 2006, addressing the freshness issue at the source and setting a precedent for domestic formula companies [2]. - The company has developed a production standard centered on "fresh raw milk once into powder" technology, which has become a benchmark for domestic infant formula, contributing to the second upgrade of freshness quality standards in the industry [2]. Group 3: Nutritional Quality and Production Efficiency - Feihe's proprietary low-temperature extraction process for key raw materials, such as whey protein, allows for a freshness level 23 times greater than traditional imported ingredients, with improved amino acid composition and protein structure [2][3]. - The company has built multiple domestic production lines for core raw materials, achieving self-research and production capabilities for 11 key ingredients, thus addressing supply chain risks associated with imported materials [3]. Group 4: Product Launch and Clinical Validation - The products "Jicui" and "Qicui" are the first to fully implement the fresh raw material traceability system, achieving a freshness enhancement of at least 23 times [3]. - These products adhere to Feihe's principle of "clinical first, then market," utilizing rigorous RCT (randomized controlled trial) testing to ensure high-quality feeding standards [3].

Core Viewpoint - The event "Seeking Traces · Fresh Vitality Ceremony" held by Feihe in collaboration with "Harper's Bazaar" marks the launch of two new products, "Jicui" and "Qicui," which embody the new standard of "fresh nutrition" in infant formula. The introduction of the world's first fresh raw material traceability system for infant formula is a significant milestone in the industry, redefining the standards of freshness and safety in the sector [1][3][12]. Group 1: New Product Launch and Innovations - Feihe has launched two new products, "Jicui" and "Qicui," which utilize the newly established fresh raw material traceability system, achieving a freshness improvement of at least 23 times compared to traditional imported ingredients [5][12]. - The traceability system allows consumers to access detailed production information of core ingredients like whey protein and lactoferrin through a simple QR code scan, enhancing transparency and trust in product safety [3][4]. - The new products are designed to closely mimic the nutritional profile of breast milk, focusing on the synergistic effects of nutrients rather than just increasing individual nutrient levels [10][12]. Group 2: Industry Impact and Standards - Feihe's introduction of the fresh raw material traceability system signifies a third revolution in the freshness of infant formula, setting a new benchmark for the industry [3][4]. - The company has established a fully controlled supply chain for core raw materials, which supports the production of fresh and safe infant formula, thereby enhancing the overall quality standards in the industry [4][5]. - Feihe's commitment to research and development has led to significant advancements in the understanding of breast milk and its active nutrients, positioning the company as a leader in the field of infant nutrition [8][10]. Group 3: Brand Ambassadors and Consumer Engagement - The event featured brand ambassadors like Zhu Zhu and Xi Mengyao, who shared their personal experiences and emphasized the importance of transparency and freshness in infant nutrition [6][7]. - The engagement of celebrity mothers in discussions about the "fresh vitality" of infant formula highlights the growing consumer demand for quality and safety in baby food products [7][12]. - Feihe's focus on scientific validation and clinical trials for its products aims to build consumer confidence and establish a new standard for selecting infant formula [10][12].

Core Viewpoint - The event "Seeking Freshness: The Fresh Vitality Ceremony" held by Feihe in collaboration with "Harper's Bazaar" marks the launch of two new products, "Jicui" and "Qicui," which embody the concept of "fresh nutrition" and emphasize the importance of fresh raw materials in infant formula [1][25]. Group 1: New Product Launch and Innovations - Feihe has introduced the world's first fresh raw material traceability system for infant formula, allowing consumers to trace the production information of key ingredients like whey protein and lactoferrin through a simple QR code scan [3][6][27]. - The new products "Jicui" and "Qicui" utilize Feihe's self-produced fresh raw materials, achieving a freshness level at least 23 times higher than traditional imported ingredients [34][41]. - The products are designed based on clinical evidence, adhering to the highest standards of randomized controlled trials (RCT) to ensure their effectiveness and safety for infants [34][41]. Group 2: Industry Impact and Standards - Feihe's innovations are seen as a driving force behind the third "freshness revolution" in the infant formula industry, redefining the standards of "freshness" and "safety" [3][25][29]. - The company has established a comprehensive control over its supply chain, from raw material sourcing to production, which enhances the transparency and quality of its products [30][32]. - Feihe's commitment to research and development has positioned it as a leader in the Chinese infant formula market, with significant achievements in maternal milk research and a robust database of over 20,000 breast milk samples [39][40]. Group 3: Brand Ambassadors and Consumer Engagement - The event featured brand ambassadors like Zhu Zhu and Xi Mengyao, who shared their personal experiences and emphasized the importance of transparency and trust in choosing infant formula [15][36]. - The engagement with mothers and industry experts during the event highlighted the growing recognition of Feihe's "fresh nutrition" philosophy and its alignment with consumer expectations for quality and safety [38][44]. - Feihe's focus on scientific feeding practices and its innovative approach to product development are expected to set new benchmarks in the industry, influencing future purchasing decisions among parents [43][44].

Core Insights - The event "Seeking Traces · Fresh Vitality Ceremony" held by Feihe in collaboration with Harper's Bazaar showcased the launch of two new products, "Jilu" and "Qicui," which represent a new standard of "fresh nutrition" [1][10][23] Group 1: New Product Launch and Innovations - Feihe introduced the world's first fresh raw material traceability system for infant formula, marking a significant advancement in the industry and redefining the standard for "freshness" [2][5][9] - The traceability system allows consumers to access detailed production information of key ingredients like whey protein and lactoferrin through a simple QR code scan, enhancing transparency and safety [5][6][10] - The new products "Jilu" and "Qicui" utilize Feihe's self-produced fresh raw materials, achieving a freshness improvement of at least 23 times compared to traditional imported ingredients [10][20] Group 2: Industry Impact and Standards - Feihe's initiatives are seen as leading the third "freshness revolution" in the infant formula industry, with a focus on self-sourced, high-quality raw materials to mitigate risks associated with imported ingredients [6][9][23] - The company has established a comprehensive control over its supply chain, ensuring that the core nutritional ingredients are produced domestically, thus enhancing the overall quality and safety of its products [9][17] - Feihe's commitment to research and development is evident, having built the largest breast milk database in China and leading in multiple categories such as breast milk research and infant formula patents [17][19] Group 3: Consumer Engagement and Brand Ambassadors - The event featured brand ambassadors like Zhu Zhu and Xi Mengyao, who shared their personal experiences and emphasized the importance of transparency and quality in choosing infant formula [12][13][16] - The discussions among mothers at the event highlighted the growing recognition of Feihe's "fresh nutrition" philosophy and its practical implications for infant feeding [16][23] - Feihe's focus on scientific validation through rigorous clinical trials ensures that its products meet the highest standards of efficacy and safety, further solidifying its position in the market [20][23]